State of Alaska, Department of Revenue - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 208 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.

Quarter-by-quarter ownership
State of Alaska, Department of Revenue ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$608
-21.9%
10,158
-5.9%
0.01%
-11.1%
Q2 2023$778
-3.7%
10,797
-1.8%
0.01%
-10.0%
Q1 2023$808
+8.3%
10,990
-1.7%
0.01%
+11.1%
Q4 2022$746
-99.9%
11,175
+0.6%
0.01%
-30.8%
Q3 2022$956,000
-15.9%
11,105
-12.9%
0.01%
-7.1%
Q2 2022$1,137,000
-13.1%
12,753
+9.7%
0.01%0.0%
Q1 2022$1,308,000
-28.4%
11,628
-1.7%
0.01%
-22.2%
Q4 2021$1,827,000
+7.8%
11,833
-2.8%
0.02%
+5.9%
Q3 2021$1,695,000
+400.0%
12,168
+370.5%
0.02%
+466.7%
Q2 2021$339,000
-14.4%
2,586
-0.7%
0.00%
-25.0%
Q1 2021$396,000
+52.9%
2,603
-0.4%
0.00%
+33.3%
Q4 2020$259,000
-0.8%
2,613
-4.6%
0.00%0.0%
Q3 2020$261,000
-18.2%
2,739
-4.0%
0.00%
-25.0%
Q2 2020$319,000
+54.9%
2,854
+0.5%
0.00%
+33.3%
Q1 2020$206,000
-31.6%
2,839
-1.7%
0.00%
-25.0%
Q4 2019$301,000
-10.4%
2,887
-14.6%
0.00%
-20.0%
Q3 2019$336,000
-82.6%
3,382
-51.8%
0.01%
-84.4%
Q3 2018$1,927,000
+33.5%
7,022
+0.8%
0.03%
+23.1%
Q2 2018$1,443,000
+28.4%
6,967
+2.4%
0.03%
+13.0%
Q1 2018$1,124,000
+95.1%
6,807
+61.8%
0.02%
+64.3%
Q4 2017$576,000
+2.3%
4,207
+1.7%
0.01%
-51.7%
Q3 2017$563,000
+23.5%
4,137
+10.1%
0.03%
-6.5%
Q2 2017$456,000
+105.4%
3,757
+78.9%
0.03%
+93.8%
Q1 2017$222,000
+6.2%
2,100
+1.9%
0.02%
-20.0%
Q4 2016$209,0002,0600.02%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Knott David M Jr 115,000$7,6822.90%
VILLERE ST DENIS J & CO LLC 483,347$32,2872.52%
Monarch Partners Asset Management LLC 62,327$4,163,4441.23%
Chicago Capital, LLC 319,054$21,312,8201.18%
RICE HALL JAMES & ASSOCIATES, LLC 285,634$19,080,3511.09%
Stephens Investment Management Group LLC 454,416$30,713,9770.56%
Smith, Graham & Co., Investment Advisors, LP 65,372$4,366,8500.53%
WOODSTOCK CORP 55,014$3,674,9350.49%
Court Place Advisors, LLC 15,533$1,037,6050.38%
ISTHMUS PARTNERS, LLC 19,830$1,324,6440.20%
View complete list of LIGAND PHARMACEUTICALS INC shareholders